Introduction
are proposed. 2, 3 Compared with treatment of cartilage defects in general, there is a lack of published information about the management of failed cartilage repair. In addition, only in the last years, the attention on the effect of a previous cartilage surgery on a subsequent revision cartilage restoration has increased. The aims of the present review are to report the rate and risk factors for failure of most common surgical repair techniques in general population and in patients with a previous failed cartilage repair, and highlight the most important factors that could influence the choice of a specific surgical treatment to revise a failed cartilage repair.
Methods
To identify relevant papers dealing with failures of cartilage repair of the knee and their surgical management, we performed a literature research on failures of cartilage repair in English language using the PubMed database with the search entries "failure" OR "failed" AND "reoperation" OR "revision" AND "cartilage" AND "knee." Two hundred fiftythree papers, published in the last 10 years, were extracted. Two authors independently reviewed each title and abstract. Once a paper was identified as likely to be included, full-text versions were obtained. Conflict about the inclusion of a paper was resolved by further evaluation by the senior author. Two hundred twenty-two papers were excluded from the analysis for the following reasons: 209 did not evaluate the outcomes of interest, 6 were review articles, 1 was not in English, and 6 were case reports. Therefore, 31 papers were finally included (►Fig. 1). These papers are summarized in ►Table 1.
Results

Microfracture
Salzmann et al 4 conducted a retrospective study on a large cohort of 454 patients (mean defect size, 2.97cm 2 ) treated by microfracture (MF). In this study, patients that underwent revision surgery at the index knee joint with pain related to the initial surgical site were described as "failure." Subjects with history of any trauma leading to reoperation at the index knee following the initial MF were excluded. The failure rate was 27.1% (123 patients) and the mean time between initial MF and reoperation was 1.6 years. Failure subjects had significantly more previous surgeries to the index knee, and interestingly, significantly smaller total defect dimensions/knee, and a smaller dimension of the largest lesion of the knee joint. Solheim 2 ) treated with MF. In this study, 2-year follow-up was obtained in 22 of 26 patients with an average of 5.8 years. Failure criteria were not specified. The authors reported that three patients had Lysholm scores of less than 80 at a minimum of 2 years after MF surgery. All three patients were females and 18 years old. Two underwent MF of the patella and one underwent MF of the trochlear groove. The patient who underwent trochlear groove MF had a revision MF after 1 year from the initial MF procedure. No other patient required revision.
Osteochondral Autograft Transplantation
In a long-term (minimum 10 years of follow-up) randomized controlled trial (RCT), Bentley et al 7 compared ACI versus mosaicplasty. One hundred consecutive patients with a symptomatic articular cartilage lesion were randomized to undergo either ACI or mosaicplasty. The failure criteria adopted by the authors were clinically poor results with arthroscopic evidence of failure of the graft, or revision surgery for any kind of defect. Forty-two patients (mean defect size, 4 cm 2 ) were enrolled in the group treated by mosaicplasty. Among this group, a high failure rate was recorded (23 out of 42 patients, 55%), with a mean time from the index procedure to revision surgery of 4.3 years. Compared with ACI, mosaicplasty showed a statistically significant higher number of failures (p < 0.001). The authors declared that the mosaicplasty group remained relatively satisfactory for the first 2 years, and then experienced a steep failure rate over the next 2 years. Of the 23 failed patients, 9 underwent revision surgery with ACI, 3 were revised with matrix-induced autologous chondrocyte implantation (MACI), 3 were converted to unicompartmental knee replacement (UKR), 1 to total knee replacement (TKR), 1 to patellofemoral joint (PFJ) replacement, and 1 to combined medial and PFJ replacement. Five patients were classified as unknown or revised elsewhere. ) who underwent OAT (mosaicplasty) with a mean follow-up of 5.9 years. The following were considered as failures by the authors: degeneration of the articular surface, Failed Cartilage Repair Rosa et al. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. Failed Cartilage Repair Rosa et al. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. Failed Cartilage Repair Rosa et al. ) with full-thickness patellar and/or trochlear cartilage lesions and a median follow-up of 3.1 years. The author considered the ACI treatment as failed when patients had an operation after implantation that necessitated removal of the graft, confirmed partial or full delamination of the graft, confirmed a loss of defect fill, or violated the subchondral bone. The failure rate was 7.89% (three patients): two failed patients were treated by MF, whereas another patient had acute knee sepsis and the implants were removed.
Minas et al 14 reported on 153 patients (155 knees; mean size of primary lesion, 6.7 cm 2 ) with evidence of early osteoarthritis (peripheral intra-articular osteophyte formation and/or 0 to 50% joint space narrowing at X-rays or normal radiographs but evidence of kissing lesions or generalized chondromalacia noted at the time of surgery) treated with ACI (periosteal patch) and a mean follow-up of 5.35 years. Twelve of the 155 knees (8%) were considered treatment failures and revised to partial (2) or total (10) joint arthroplasty at an average of 3.17 years after ACI. Subsequent surgical procedures (SSP) after the index implantation were performed in 95 of the 155 knees (61%). In 21 knees, the indication for SSP was partial graft delamination affecting less than 20% of the defects, and treated with either MF (8) ) who underwent isolated OCA transplantation of the femoral condyle; 13.5 years was the median follow-up of patients whose grafts were not surgically removed at the time of follow-up. The majority of knees had one or more surgeries before OCA transplantation, including cartilage repair surgery. The authors defined OCA failure as revision of the graft or conversion to partial or TKR. Based on these failure criteria, 31 knees (24%) were classified as failure with a mean time to failure of 7.2 years. Fifteen failure patients underwent revision OCA transplantation, 13 were converted to TKA, and 3 to unicompartmental knee arthroplasty (UKA). Age and number of previous surgeries were associated with OCA failure after checking the other variables at the logistic regression.
Sadr . All patients were followed prospectively with a minimum follow-up of 2 years. The treatment failed in five patients, one patient underwent UKR, one sustained a HTO, one patient was treated with autologous osteochondral transplantation, and another one with OCA transplantation and concomitant distal femoral osteotomy (DFO). The last failure continued the treatment in another institution.
Treatment of Failed Cartilage Repair
Gracitelli et al 30 analyzed a population of 163 patients (164 knees; mean graft size, 6.8 cm 2 ) treated with OCA transplantation after previous failed cartilage repair. Patients had a minimum follow-up of 2 years (mean of 8.5 in subjects whose grafts were still in situ). SMS was the most common isolated previous procedure (88.4%). The authors considered any reoperation resulting in removal of the graft as failure. The authors reported an improvement in pain and function from preoperatively to the latest follow-up in all functional scores used (modified Merle d' Aubigné-Postel [18-point] , the international knee documentation committee [IKDC] score, the Knee Injury and Osteoarthritis Outcome Score [KOOS] , and Knee Society Function [KS-F] score). Sixty-eight knees (41.5%) had reoperations after OCA transplantation and 31 (19.02%) were considered failures. Of the 164 knees, 18 failed knees were converted to TKA, 9 had an OCA revision, 2 were converted to UKA, 1 to PFJ arthroplasty, and 1 to arthrodesis. The median time to failure was 2.6 years. Survivorship of the OCA transplantation was 87.8 and 82% at 5 and 10 years, respectively. Failure patients had a significantly increased BMI and number of previous surgeries compared with nonfailure patients. In another study, Gracitelli et al 31 compared two groups of patients who underwent OCA transplantation. A consecutive series of 46 knees that had OCA transplantation performed as a primary treatment (group 1) were matched to a nonconsecutive series of 46 knees that underwent OCA transplantation after failure of previous subchondral marrow stimulation (group 2). Any reoperation resulting in removal of the graft was defined as failure. In group 1, 11 of 46 knees (24%) underwent reoperations, and in group 2, 20 of 46 knees (44%) underwent reoperations. A significant difference in reoperation rate was found between the groups (p ¼ 0.04). Failure OCA transplantation was noted in five knees (11%) in group 1; two knees had the OCA revised and the other three were converted to TKR. In group 2, seven knees (15%) were considered failures, of which three had the OCA revised and four were converted to TKR. The failure rate was not statistically significant between the groups (p ¼ 0.53). Similar survivorship of the allograft was found at 10-year followup; 87.4% of group 1 and 86% of group 2. Patients whose grafts remained in situ had a mean follow-up of 7.8 years (41 knees in group 1) and 11.3 years (39 knees in group 2). Improvement in pain and function from the preoperative point to the latest follow-up was registered in both the groups (p < 0.001). No difference between the groups was found preoperatively, at the latest follow-up, or in the change from preoperative state to follow-up. In the study of Frank et al, 20 Kaplan-Meier survival analysis was performed on a population of 180 patients treated with OCA transplantation, and no significant difference in survival distributions of OCA transplantation between patients with and without a history of previous MF was registered at log-rank test (p ¼ 0.370).
Horton et al 32 reported data of 33 knees (mean graft area, 9.5 cm 2 ) that underwent revision OCA transplantation of the knee after failure of primary OCA. All included patients had undergone surgery at least 2 years ago with a minimum follow-up of 2 years. The mean follow-up after receiving a revision OCA transplantation was 10 years. The authors classified any patient as revision allograft failure who underwent conversion to partial or TKA. Thirteen patients (39%) underwent graft-related surgery and were considered failures. Of these, 1 was converted to UKA and 12 were converted to TKA with a mean time to failure of 5.5 years. Revision graft survivorship was 79 and 61% at 5 and 10 years, respectively. The authors reported an increased incidence of failure and conversion to partial or TKA in older patients, patients with diagnosis of OA, and those who had a progression of cartilage disease at the time of revision OCA transplantation. However, sample size was too small to assess which variables predicted allograft failure. In the RCT of Bentley et al, OAT (mosaicplasty) led to revision surgery in more than 50% of the cases in approximately 4 years. 7 Better results were showed in mid-term follow-up in patients with small cartilage defects. 8, 9 Based on the results of Degen et al, the use of mosaicplasty in patients older than 40 years with focal cartilage defects but with untreated regions of the knee no worse than Outerbridge grade 2, may be a viable options at short-/mid-term.
9
ACI provides satisfactory results in terms of both pain relief and knee function rehabilitation in patients with large full-thickness chondral and osteochondral defects of the knee. 35 In the study of Minas et al, 14 the failure rate of periosteum-covered ACI was 25%. It is important to highlight that this result was recorded in a population with a minimum follow-up of 10 years. Furthermore, the total surface area treated per knee was 8. 
18
The use of OCA transplantation in a population without previous cartilage repair surgery showed a failure rate of 18% at a median time of 3.5 years. Degenerative chondral lesions, larger graft size, and patellofemoral location are probably related to an increased risk of failure. 19 In the large cohort of 
22
Regarding treatment of chondral defects of the patella, the failure rate seemed to be higher and the mean time to revision shorter. 23 The same results were reported for bipolar cartilage lesions. In this case, a larger allograft size showed correlation to a higher failure rate. 24 Murphy et al 25 reported that in patients younger than 18 years, OCA transplantation can be considered a valuable treatment for large symptomatic osteochondral lesions in the knee (12% of failure rate in a population with a mean follow-up of 8.4 years).
25
SDOCA implants showed a very high failure rate. Furthermore, this result was recorded in a short follow-up time.
26
The use of TruFit plug for the treatment of small cartilage defects seemed to be related to a higher failure rate at shortterm, 27 especially if used to treat patellar defects. 28 Conversely, the treatment of osteochondral lesions with MaioRegen showed promising results in terms of survivorship at short term.
29
Regarding the treatment of failed cartilage repair, the use of OCA transplantation in patients with previous failed cartilage repair may be a safe option. In this situation, OCA showed a failure rate similar to that reported in general population and significant improvement of functional scores from preoperative condition. After a failed cartilage repair, patients treated by OCA transplantation with higher BMI and a greater number of previous surgeries seemed to have an increased risk of failure. 30 In patients with previous failed SMS, compared with those with no previous cartilage repair, OCA transplantation showed a statistically significant rate of reoperation but not of failure. At long-term follow up, the survivorship was similar. 20, 31 In clinical and functional scores, patients with previous failed SMS demonstrated an improvement similar to patients treated with OCA transplantation as primary treatment. 31 Even if these results were derived from a small size sample, the revision of failed OCA In conclusion, management of failed cartilage repair depends on the type of failed surgical treatment. OCA transplantation seems to be the most reliable treatment, especially in the presence of a previous failed SMS. ACI or MACI showed acceptable results in patients with previously failed MACI or ACI, but this hypothesis should be confirmed by further studies. According to the findings of this review, we retain that great attention should be paid to the condition of the subchondral bone when approaching a patient with history of failed cartilage repair.
